chr12-132618878-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_170682.4(P2RX2):c.62G>A(p.Cys21Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00047 in 1,378,608 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00039 ( 1 hom., cov: 29)
Exomes 𝑓: 0.00048 ( 12 hom. )
Consequence
P2RX2
NM_170682.4 missense
NM_170682.4 missense
Scores
1
4
13
Clinical Significance
Conservation
PhyloP100: 2.92
Genes affected
P2RX2 (HGNC:15459): (purinergic receptor P2X 2) The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel. Binding to ATP mediates synaptic transmission between neurons and from neurons to smooth muscle. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0071820617).
BP6
Variant 12-132618878-G-A is Benign according to our data. Variant chr12-132618878-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 737145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 59 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P2RX2 | NM_170682.4 | c.62G>A | p.Cys21Tyr | missense_variant | 1/11 | ENST00000643471.2 | NP_733782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P2RX2 | ENST00000643471.2 | c.62G>A | p.Cys21Tyr | missense_variant | 1/11 | NM_170682.4 | ENSP00000494644 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000386 AC: 58AN: 150308Hom.: 1 Cov.: 29
GnomAD3 genomes
AF:
AC:
58
AN:
150308
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00111 AC: 142AN: 128490Hom.: 2 AF XY: 0.00159 AC XY: 116AN XY: 73002
GnomAD3 exomes
AF:
AC:
142
AN:
128490
Hom.:
AF XY:
AC XY:
116
AN XY:
73002
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000480 AC: 589AN: 1228192Hom.: 12 Cov.: 31 AF XY: 0.000671 AC XY: 405AN XY: 603610
GnomAD4 exome
AF:
AC:
589
AN:
1228192
Hom.:
Cov.:
31
AF XY:
AC XY:
405
AN XY:
603610
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000392 AC: 59AN: 150416Hom.: 1 Cov.: 29 AF XY: 0.000599 AC XY: 44AN XY: 73474
GnomAD4 genome
AF:
AC:
59
AN:
150416
Hom.:
Cov.:
29
AF XY:
AC XY:
44
AN XY:
73474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
182
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 21, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 04, 2022 | See Variant Classification Assertion Criteria. - |
P2RX2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 26, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D;.;.;.;.;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;T;T;T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;M;M;M;M;M;M;M;.
MutationTaster
Benign
D;D;D;D;D;N;N
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
.;D;D;D;D;D;D;D;.
REVEL
Benign
Sift
Benign
.;T;T;T;D;T;D;T;.
Sift4G
Uncertain
.;D;D;D;D;D;D;D;D
Polyphen
D;D;P;D;B;D;B;D;D
Vest4
0.51, 0.32, 0.61, 0.39, 0.57, 0.59, 0.56, 0.52
MutPred
Gain of MoRF binding (P = 0.0741);Gain of MoRF binding (P = 0.0741);Gain of MoRF binding (P = 0.0741);Gain of MoRF binding (P = 0.0741);Gain of MoRF binding (P = 0.0741);Gain of MoRF binding (P = 0.0741);Gain of MoRF binding (P = 0.0741);Gain of MoRF binding (P = 0.0741);Gain of MoRF binding (P = 0.0741);
MVP
0.48
MPC
2.4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at